Janssen-Cilag International NV:
Please note that on November 18, 2026, CDI sent the Notification of Drug Oversea Inspection Results of Lazertinib Mesylate Tablets to the agency of the medicine in China.
If there are any questions, please do not hesitate to contact us as soon.
Contact: Zheng Xiao
Tel.+86 10 68441660
Center for Drug Inspection of NMPA
November 18, 2026